BASF SE (BAS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BASF SE (BAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9977
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BASF SE (BASF) is a chemical company, which carries out the research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, electronic chemicals, concrete admixtures, pigments, paints, food additives, fungicides, and herbicides. BASF also focuses on the exploration and production in oil and gas-rich regions in Europe, North Africa, Russia, South America and the Middle East. The company caters to a wide range of industries including construction, furniture and wood, agriculture, paper and pulp, electronics and electrical, paints and coatings, automotive, home care, nutrition, chemicals and others. BASF carries out R&D in alliance with global customers, scientists and partners. The company operates through a network of manufacturing facilities across the world. It has presence in Europe, Asia-Pacific, South America, Africa, the Middle East and North America. BASF is headquartered in Ludwigshafen, Germany.

BASF SE (BAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BASF SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BASF SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BASF SE, Medical Devices Deals, 2012 to YTD 2018 9
BASF SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BASF SE, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biocrates Life Sciences Raises Funds through Venture Financing 11
Allylix Raises US$18.2 Million In Series D Financing 12
Partnerships 13
Pion Partners with BASF 13
Catalent Pharma Solutions Enters Into Agreement With BASF 14
Licensing Agreements 15
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Asset Transactions 16
Siegfried Acquires API Businesses from BASF 16
Acquisition 17
Biocrates Life Sciences Acquires Metanomics Health 17
Merck And BASF Acquire Majority Stake In Innovation Lab 18
BASF Completes Acquisition Of Pronova BioPharma 19
Basf Acquires Equateq, Manufacturer Of Omega-3 Fatty Acids 21
BASF SE – Key Competitors 22
BASF SE – Key Employees 23
BASF SE – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 28
Recent Developments 29
Government and Public Interest 29
Apr 18, 2018: World Malaria Summit 2018: Bayer commits to provide innovative vector control solutions to help eradicate malaria by 2040 29
Other Significant Developments 30
Aug 16, 2018: Benefits of omega-3 long-chain fatty acids in patients with non-alcoholic fatty liver disease revealed in meta-analysis of 18 studies 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
BASF SE, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BASF SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BASF SE, Deals By Therapy Area, 2012 to YTD 2018 8
BASF SE, Medical Devices Deals, 2012 to YTD 2018 9
BASF SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocrates Life Sciences Raises Funds through Venture Financing 11
Allylix Raises US$18.2 Million In Series D Financing 12
Pion Partners with BASF 13
Catalent Pharma Solutions Enters Into Agreement With BASF 14
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Siegfried Acquires API Businesses from BASF 16
Biocrates Life Sciences Acquires Metanomics Health 17
Merck And BASF Acquire Majority Stake In Innovation Lab 18
BASF Completes Acquisition Of Pronova BioPharma 19
Basf Acquires Equateq, Manufacturer Of Omega-3 Fatty Acids 21
BASF SE, Key Competitors 22
BASF SE, Key Employees 23
BASF SE, Subsidiaries 24
BASF SE, Joint Venture 28

List of Figures
BASF SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BASF SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BASF SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BASF SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BASF SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BASF SE, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BASF SE (BAS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Hospital for Sick Children-製薬・医療分野:企業M&A・提携分析
    Summary The Hospital for Sick Children (SickKids) is a healthcare service provider that offers children care services. The hospital offers programs and services including resources, tele-medicine, accommodations, child life, creative arts therapy, child and family-centered care; health records inqui …
  • BorgWarner Inc.:企業の戦略・SWOT・財務情報
    BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report Summary BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ultrastroy Eood:企業の戦略的SWOT分析
    Ultrastroy Eood - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Collagen Solutions Plc (COS):製品パイプライン分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • Avgol Industries 1953 Ltd. (AVGL):企業の財務・戦略的SWOT分析
    Avgol Industries 1953 Ltd. (AVGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mirabilis Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a medical device company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, pregnancy …
  • Toshiba Corporation:企業のM&A・事業提携・投資動向
    Toshiba Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toshiba Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, …
  • Sterigenics International LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sterigenics International LLC (SteriGenics), formerly Radiation Sterilizers Inc, a subsidiary of Gtcr Llc, is a medical device company that offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. The company was formerly known as Radiation Sterilizers, …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China General Nuclear Power Corp:電力:M&Aディール及び事業提携情報
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • BioMotiv LLC:医療機器:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • Bechtel Corp:企業の戦略的SWOT分析
    Bechtel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dexia Group:戦略・SWOT・企業財務分析
    Dexia Group - Strategy, SWOT and Corporate Finance Report Summary Dexia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. It also provides installation and service of various types of whole-house …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Total SA (FP):石油・ガス:M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆